|
NCSTN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.227600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.58499999997264E-06 |
| Normal-vs-Stage2 |
4.404000E-01 |
| Normal-vs-Stage3 |
4.304200E-01 |
| Normal-vs-Stage4 |
9.688200E-01 |
| Stage1-vs-Stage2 |
8.011700E-02 |
| Stage1-vs-Stage3 |
3.064100E-03 |
| Stage1-vs-Stage4 |
3.201700E-02 |
| Stage2-vs-Stage3 |
2.434000E-01 |
| Stage2-vs-Stage4 |
5.873800E-01 |
| Stage3-vs-Stage4 |
6.551200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.004670E-03 |
| Normal-vs-AfricanAmerican |
2.014100E-02 |
| Normal-vs-Asian |
3.278000E-01 |
| Caucasian-vs-AfricanAmerican |
9.800600E-01 |
| Caucasian-vs-Asian |
9.159400E-01 |
| AfricanAmerican-vs-Asian |
9.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88767000000034E-05 |
| Normal-vs-Female |
8.916200E-01 |
| Male-vs-Female |
7.796300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.691500E-02 |
| Normal-vs-Extreme_Weight |
2.70359999998693E-06 |
| Normal-vs-Obese |
6.092300E-02 |
| Normal-vs-Extreme_Obese |
3.163300E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.148100E-02 |
| Normal_Weight-vs-Obese |
9.413400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.520600E-01 |
| Extreme_Weight-vs-Obese |
4.228300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.404800E-01 |
| Obese-vs-Extreme_Obese |
3.105600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.971200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.800300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.58320000000134E-05 |
| Normal-vs-Age(81-100Yrs) |
3.005000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.067000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.746200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.092000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.067600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.013620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.559000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.41200000000919E-06 |
| Normal-VS-Type2 PRCC |
3.154200E-02 |
| Normal-VS-KIRP CIMP |
5.376300E-02 |
| Normal-VS-Unclassified PRCC |
2.660600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.206040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.900000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.218400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.405100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.233800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.647900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.255700E-03 |
| Normal-vs-N1 |
8.329700E-02 |
| Normal-vs-N2 |
2.466600E-01 |
| N0-vs-N1 |
3.158800E-03 |
| N0-vs-N2 |
1.882310E-02 |
| N1-vs-N2 |
7.446800E-01 |
|
|
